Health ❯ Healthcare

Pharmaceuticals

Drug Development Drug Approval Clinical Trials Drug Safety Drug Pricing Weight Loss Cancer Treatment Weight Loss Drugs Drug Regulation Medications

FDA Staff Say Evidence Is Insufficient to Allow Seven Peptides for Compounding

A reshaped advisory committee will meet July 23–24 to offer a non-binding recommendation that could guide the agency's final decision.

Regulators Move to Strip Approval of Tavneos After Trial Misconduct and Liver Safety Signals

FDA Grants Priority Review to Roche’s Enspryng for Thyroid Eye Disease

Zymeworks to Buy Theravance for $929 Million

Stories older than 24h

FDA Approves Lumvoa for Thyroid Eye Disease

Generics and Pills Expand Access to GLP‑1s, but Uptake and Coverage Remain Uneven

EU Opens Antitrust Probe Into Sanofi Over Efluelda Flu Vaccine

Oxford Tool Predicts Individual Risk of Serious Statin-Related Muscle Disorders

EMA Committee Recommends Revoking Tavneos Authorization

Lawmakers Demand Answers After Single Patient Received Experimental Eli Lilly Obesity Drug

Trodelvy Approved in U.S. and EU as First‑Line Option for Metastatic Triple‑Negative Breast Cancer

AbbVie to Buy Apogee for About $10.9 Billion to Add Clinical-Stage IL-13 Drug

Study Finds Common GLP‑1 Use and Misuse Among People With Eating Disorders

One 79-Year-Old Granted Compassionate‑Use Access to Eli Lilly’s Unapproved Obesity Drug

FDA Classifies Chlorthalidone Recall as Class II

UK Clears Oral Wegovy and Foundation Pledges Europe Research Cash

Nationwide Recall of 25 mg Chlorthalidone Covers 11,460 Bottles

AbbVie Agrees to Buy Apogee Therapeutics for $10.9 Billion

Oral GLP‑1s Reshape Obesity Market as Approvals, Policy Talks and M&A Accelerate Growth

Pfizer Lung Cancer Drug Fails to Improve Survival in Late‑Stage Trial